Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2003
12/03/2003CN1459280A Usage of immunopotentiation by using resveratrol
12/03/2003CN1129605C Modified aminoacids, pharmaceuticals containing these compounds and mehtod for their prodn
12/03/2003CN1129603C Heterocycles, its preparation, application and medicine contanining same
12/03/2003CN1129602C 11-(substituted phenyl) estra-4,9-diene derivatives
12/03/2003CN1129601C Pseudo gensenoside Pgq and its semi synthesis and medicinal use
12/03/2003CN1129582C 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators
12/03/2003CN1129576C Phenyl heterocyclic compound used as epoxy enzyme-2 inhibitor
12/03/2003CN1129453C Mycobacterium vaccae for down regulation of Th2 activity of immune system
12/02/2003US6657104 Cell-based, and whole-animal-based assays for detecting substances having therapeutic activity toward cardiac hypertrophy.
12/02/2003US6657060 Neuropeptide Y antagonists; treatment of eating disorders such as obesity and hyperphagia
12/02/2003US6657055 Detection of modulators of immune response; obtain cell sample, incubate with fusion proteins, monitor cells for immune response
12/02/2003US6657047 Nucleotide sequences coding polypeptide for use in the treatment of tumors, inflammation, psoriasis, rheumatoid arthritis, cardiovascular and vision disorders
12/02/2003US6656971 Non-peptidic small organic compounds having an affinity for cyclophilin (CyP)-type immunophilins; inhibiting their peptidyl-prolyl isomerase activity; treating variety of medical conditions
12/02/2003US6656966 Nitrosated and nitrosylated taxanes, compositions and methods of use
12/02/2003US6656965 HIV protease inhibitors based on amino acid derivatives
12/02/2003US6656964 Reducing levels of tumor necrosis factor alpha; inhibition of undesireable levels of matrix metalloproteinases
12/02/2003US6656960 Administering drug to produce cardiac asystole upon stimulation of one or both vagus nerves; inserting an electrode into esophagus of patient; actuating electrode to create an electrical field effective to stimulate vagus nerve
12/02/2003US6656959 PDE IV inhibiting pyridine derivatives
12/02/2003US6656957 Pyridine derivatives
12/02/2003US6656955 Side effect reduction; synergistic mixture
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
12/02/2003US6656945 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-one cGMP-PDE inhibitors for the treatment of erectile dysfunction
12/02/2003US6656943 1-phenyl-4-benzlpiperazines: dopamine receptor subtype specific ligands
12/02/2003US6656942 Orally active salts with tyrosine kinase activity
12/02/2003US6656939 Pyrazole compounds useful as protein kinase inhibitors
12/02/2003US6656938 Inducing cytokine biosynthesis in animals, for the treatment of diseases, including viral and neoplastic diseases
12/02/2003US6656937 Substituted glutarimides and their use as inhibitors of IL-12 production
12/02/2003US6656934 2-amino-benzoxazinone derivatives for the treatment of obesity
12/02/2003US6656933 Novel compounds which inhibit production of cytokines involved in inflammatory processes
12/02/2003US6656932 Treating osteoarthritis, rheumatoid arthritis, cancer, inflammation, and heart failure
12/02/2003US6656927 Ip3 receptor ligands
12/02/2003US6656924 Immunopotentiating compositions
12/02/2003US6656905 Cyclic tetrapeptide compound and use thereof
12/02/2003US6656729 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
12/02/2003US6656727 A retroviral vector of a heterologous nucleic acid sequence as well as at least one sequence allowing site-specific integration of the sequence into a non-coding region of a genome; gene therapy of genetic defects; viricides
12/02/2003US6656711 Fermentative preparation process for and crystal forms of cytostatics
12/02/2003US6656707 Nucleic acid molecules encoding the same; vectors, host cells, pharmaceutical compositions, selective binding agents and methods for production; antagonists and agonists; bactericides; viricides
12/02/2003US6656705 Sciellin and uses thereof
12/02/2003US6656704 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
12/02/2003US6656511 Removing phytate from vegetable protein with anion exchange resin, deamidation with cation exchange resin
12/02/2003US6656510 Antidepressants
12/02/2003US6656503 Counters ulcerogenic side effects; nonsteroidal antiinflam-matory core with polymer and misoprostol coating
12/02/2003US6656482 Spill resistant pharmaceutical system
12/02/2003US6656475 Modulating growth of muscle or adipose tissue in eukaryotic organism using agent that affects myostatin signal transduction
12/02/2003US6656474 Minimal adverse side effects
12/02/2003US6656473 Defatted meal from squash seeds containing protein-bound tryptophan and carbohydrate source (glucose, maltose, sucrose) for facilitating transport across the blood brain barrier; useful for inducing sleep
12/02/2003CA2287046C Novel dihydroquinoline and tetrahydroquinoline compounds, process for preparing them and pharmaceutical compositions containing them
12/02/2003CA2284446C New cyclic cycloalkylene chain derivatives, their preparation process and pharmaceutical compounds containing them
12/02/2003CA2249756C New indanol compounds, their preparation process and the pharmaceutical compositions containing them
11/2003
11/27/2003WO2003097872A2 G - protein coupled receptor marker molecules associated with colorectal lesions
11/27/2003WO2003097862A1 Method of searching substane having antidiabetic activity
11/27/2003WO2003097852A2 Assay for identifying inhibitors of fc gamma riii signaling
11/27/2003WO2003097849A1 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
11/27/2003WO2003097806A2 Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/27/2003WO2003097672A1 Method for controlling protein
11/27/2003WO2003097665A2 Mid 241 receptor, a novel g-protein coupled receptor
11/27/2003WO2003097659A1 6-11 bicyclic ketolide derivatives
11/27/2003WO2003097658A2 Compounds and methods for inhibiting selectin-mediated function
11/27/2003WO2003097649A2 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
11/27/2003WO2003097648A1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the prepartion thereof
11/27/2003WO2003097647A1 Vitamin-mitomycin conjugates
11/27/2003WO2003097644A2 Non-nucleoside reverse transcriptase inhibitors
11/27/2003WO2003097642A1 Anti-tumour polycyclic carboxamides
11/27/2003WO2003097641A2 1h-imidazo[4,5-c] quinoline derivatives in the treatment of protein kinase dependent diseases
11/27/2003WO2003097639A1 Benzoxazine and benzoxazinone substituted triazoles
11/27/2003WO2003097638A1 (s)-4-amino-5-chloro-2-methoxy-n-[1-[1-(2-tetrahydrofurylcarbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor
11/27/2003WO2003097636A1 Novel compounds and their use
11/27/2003WO2003097633A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics
11/27/2003WO2003097625A1 Cytotoxic agents comprising polyethylene glycol-containing taxanes and their therapeutic use
11/27/2003WO2003097621A1 Methods of using thiazolidinedithione derivatives
11/27/2003WO2003097620A1 Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same
11/27/2003WO2003097619A1 Glucagon antagonists/inverse agonists
11/27/2003WO2003097616A1 Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
11/27/2003WO2003097613A1 Pyridazin-3(2h)-one derivatives as pde4 inhibitors
11/27/2003WO2003097611A1 Novel imidazole compounds, method for preparing same and use thereof as medicines
11/27/2003WO2003097610A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
11/27/2003WO2003097602A1 Cyanoguanidine produgs
11/27/2003WO2003097598A1 Compound exhibiting pgd 2 receptor antagonism
11/27/2003WO2003097597A2 Indole derivatives and the use thereof as cb2 receptor ligands
11/27/2003WO2003097591A1 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
11/27/2003WO2003097586A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/27/2003WO2003097573A1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
11/27/2003WO2003097564A2 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
11/27/2003WO2003097356A1 Camptothecin derivatives and polymeric conjugates thereof
11/27/2003WO2003097163A2 Using a selective inos inhibitor for the treatment of respiratory diseases and conditions
11/27/2003WO2003097108A1 Medicinal formulation in particular for treating herniated invertebral discs
11/27/2003WO2003097104A1 Treatment and prevention of tissue damage
11/27/2003WO2003097101A1 Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity
11/27/2003WO2003097091A2 Glucan-based vaccines
11/27/2003WO2003097083A1 Medicinal compositions containing ghrelin
11/27/2003WO2003097067A1 Combination of an ace inhibitor, a calcium channel blocker and a diuretic
11/27/2003WO2003097063A1 Derivatives of 2-(1-benzyl-1h-pyrazolo (3, 4-b)pyridine-3yl) -5-(4-pyridinyl)-4-pyrimidine amine and the use thereof as guanylate cyclase stimulators
11/27/2003WO2003097058A1 New pharmaceutical compositions containing flibanserin polymorph a
11/27/2003WO2003097057A1 Synergistic combination of an opioid analgesic and a nsaid
11/27/2003WO2003097056A1 Pyrroloquinoline quinone for treatment of cardiac injury and methods of use thereof
11/27/2003WO2003097053A1 Compounds, compositions, and methods
11/27/2003WO2003097052A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
11/27/2003WO2003097051A2 Use of compounds that are effective as selective opiate receptor modulators
11/27/2003WO2003097047A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/27/2003WO2003097045A1 Combination of organic compounds
1 ... 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 ... 1564